2206 GMT - The rise in China's birth rate should help improve sentiment toward The a2 Milk Company's major infant-formula market, Morgan Stanley analysts say. They warn that tangible impacts on industry volumes are expected to lag the recovery in birth rates, but nonetheless call it out as a likely positive for the Australia-listed producer. They tell clients in a note that China's latest births data implies a 5.8% on-year rise in the number of new babies in 2024. MS has an equal-weight rating and A$5.90 target price on the stock, which is at A$5.81 ahead of the open. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
January 19, 2025 17:06 ET (22:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。